Articoli con mandati relativi all'accesso pubblico - Warren SangerUlteriori informazioni
Non disponibile pubblicamente: 1
Use of immunoglobulin heavy chain primer pools to assess minimal residual disease/persistent disease (MRD/PD) in children and adolescents with mature B-cell non-Hodgkin …
B Shiramizu, S Goldman, I Kusao, M Agsalda, JC Lynch, L Harrison, ...
Journal of Clinical Oncology 28 (15_suppl), 9527-9527, 2010
Mandati: US National Institutes of Health
Disponibili pubblicamente: 24
An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities
EB Kaminsky, V Kaul, J Paschall, DM Church, B Bunke, D Kunig, ...
Genetics in medicine 13 (9), 777-784, 2011
Mandati: US National Institutes of Health
Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia
D Moreno-De-Luca, JG Mulle, EB Kaminsky, SJ Sanders, SM Myers, ...
The American Journal of Human Genetics 87 (5), 618-630, 2010
Mandati: US National Institutes of Health
Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell–like diffuse large B cell lymphoma
G Lenz, I Nagel, R Siebert, AV Roschke, W Sanger, GW Wright, SS Dave, ...
The Journal of experimental medicine 204 (3), 633-643, 2007
Mandati: German Research Foundation
Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children’s Oncology Group report
S Goldman, L Smith, JR Anderson, S Perkins, L Harrison, MB Geyer, ...
Leukemia 27 (5), 1174-1177, 2013
Mandati: US National Institutes of Health, Doris Duke Charitable Foundation
Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the …
HA Poirel, MS Cairo, NA Heerema, J Swansbury, A Auperin, E Launay, ...
Leukemia 23 (2), 323-331, 2009
Mandati: US National Institutes of Health
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow‐positive B urkitt lymphoma/leukaemia: a Children's Oncology Group Report
S Goldman, L Smith, P Galardy, SL Perkins, JK Frazer, W Sanger, ...
British journal of haematology 167 (3), 394-401, 2014
Mandati: US National Institutes of Health
Familial myeloma
HT Lynch, K Ferrara, B Barlogie, EA Coleman, JF Lynch, D Weisenburger, ...
New England Journal of Medicine 359 (2), 152-157, 2008
Mandati: US National Institutes of Health
Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling
KE Deffenbacher, J Iqbal, W Sanger, Y Shen, C Lachel, Z Liu, Y Liu, ...
Blood, The Journal of the American Society of Hematology 119 (16), 3757-3766, 2012
Mandati: US National Institutes of Health
An increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma …
M Nelson, SL Perkins, BJ Dave, PF Coccia, JA Bridge, ER Lyden, ...
British journal of haematology 148 (4), 600-610, 2010
Mandati: US National Institutes of Health
Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin‐fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression
JD Schiffman, PD Lorimer, V Rodic, MS Jahromi, JM Downie, MG Bayerl, ...
British journal of haematology 155 (4), 477-486, 2011
Mandati: US National Institutes of Health
Clonal evolution in t (14; 18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution
F d'Amore, E Chan, J Iqbal, H Geng, K Young, L Xiao, MM Hess, ...
Clinical Cancer Research 14 (22), 7180-7187, 2008
Mandati: US National Institutes of Health
Primary follicular lymphoma of the testis in children and adolescents
MA Lones, M Raphael, K McCarthy, A Wotherspoon, MJ Terrier-Lacombe, ...
Journal of pediatric hematology/oncology 34 (1), 68-71, 2012
Mandati: US National Institutes of Health
t (14; 18)-negative follicular lymphomas are associated with a high frequency of BCL6 rearrangement at the alternative breakpoint region
K Gu, K Fu, S Jain, Z Liu, J Iqbal, M Li, WG Sanger, DD Weisenburger, ...
Modern Pathology 22 (9), 1251-1257, 2009
Mandati: US National Institutes of Health
Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B‐cell lymphoma/leukaemia: a Children's Oncology …
MJ Barth, S Goldman, L Smith, S Perkins, B Shiramizu, TG Gross, ...
British journal of haematology 162 (5), 678-683, 2013
Mandati: US National Institutes of Health, Doris Duke Charitable Foundation
Minimal disease assessment in the treatment of children and adolescents with intermediate‐risk (Stage III/IV) B‐cell non‐Hodgkin lymphoma: a children’s oncology group report
B Shiramizu, S Goldman, I Kusao, M Agsalda, J Lynch, L Smith, ...
British journal of haematology 153 (6), 758-763, 2011
Mandati: US National Institutes of Health
Characterization of childhood precursor T‐lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Children's Oncology Group
KJ Smock, M Nelson, SR Tripp, WG Sanger, M Abromowitch, MS Cairo, ...
Pediatric blood & cancer 51 (4), 489-494, 2008
Mandati: US National Institutes of Health
Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component
C Visco, S Hoeller, JT Malik, ZY Xu-Monette, ML Wiggins, J Liu, ...
The American journal of surgical pathology 35 (2), 177-189, 2011
Mandati: US National Institutes of Health
Large contiguous gene deletions in Sjögren–Larsson syndrome
H Engelstad, G Carney, D S'aulis, J Rise, WG Sanger, MK Rudd, ...
Molecular genetics and metabolism 104 (3), 356-361, 2011
Mandati: US National Institutes of Health
Impact of persistent minimal residual disease post‐consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report
B Shiramizu, S Goldman, L Smith, M Agsalda‐Garcia, P Galardy, ...
British journal of haematology 170 (3), 367-371, 2015
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software